 | • レポートコード：MRC2312MG12638 • 出版社/出版日：Market Monitor Global / 2023年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、68ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥471,250 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥706,875 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の滅菌注射剤受託製造市場規模と予測を収録しています。・世界の滅菌注射剤受託製造市場：売上、2018年-2023年、2024年-2029年 ・世界の滅菌注射剤受託製造市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の滅菌注射剤受託製造市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「低分子」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 滅菌注射剤受託製造のグローバル主要企業は、Baxter、 Boehringer Ingelheim、 Catalent、 Grifols S.A.、 Vetter Pharma、 Recipharm AB、 Aenova Group、 Fresenius Kabi、 Unither Pharmaceuticals、 Next Pharma Technologiesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、滅菌注射剤受託製造のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の滅菌注射剤受託製造市場：タイプ別、2018年-2023年、2024年-2029年 世界の滅菌注射剤受託製造市場：タイプ別市場シェア、2022年 ・低分子、高分子 世界の滅菌注射剤受託製造市場：用途別、2018年-2023年、2024年-2029年 世界の滅菌注射剤受託製造市場：用途別市場シェア、2022年 ・病院、研究所、その他 世界の滅菌注射剤受託製造市場：地域・国別、2018年-2023年、2024年-2029年 世界の滅菌注射剤受託製造市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における滅菌注射剤受託製造のグローバル売上、2018年-2023年 ・主要企業における滅菌注射剤受託製造のグローバル売上シェア、2022年 ・主要企業における滅菌注射剤受託製造のグローバル販売量、2018年-2023年 ・主要企業における滅菌注射剤受託製造のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Baxter、 Boehringer Ingelheim、 Catalent、 Grifols S.A.、 Vetter Pharma、 Recipharm AB、 Aenova Group、 Fresenius Kabi、 Unither Pharmaceuticals、 Next Pharma Technologies ************************************************************* ・調査・分析レポートの概要 滅菌注射剤受託製造市場の定義 市場セグメント 世界の滅菌注射剤受託製造市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の滅菌注射剤受託製造市場規模 世界の滅菌注射剤受託製造市場規模：2022年 VS 2029年 世界の滅菌注射剤受託製造市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの滅菌注射剤受託製造の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の滅菌注射剤受託製造製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：低分子、高分子 滅菌注射剤受託製造のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、研究所、その他 滅菌注射剤受託製造の用途別グローバル売上・予測 ・地域別市場分析 地域別滅菌注射剤受託製造市場規模 2022年と2029年 地域別滅菌注射剤受託製造売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Baxter、 Boehringer Ingelheim、 Catalent、 Grifols S.A.、 Vetter Pharma、 Recipharm AB、 Aenova Group、 Fresenius Kabi、 Unither Pharmaceuticals、 Next Pharma Technologies ... |
This research report provides a comprehensive analysis of the Sterile Injectable Contract Manufacturing market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Sterile Injectable Contract Manufacturing market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Sterile Injectable Contract Manufacturing, challenges faced by the industry, and potential opportunities for market players.
The global Sterile Injectable Contract Manufacturing market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Sterile Injectable Contract Manufacturing market presents opportunities for various stakeholders, including Hospital, Research Laboratory. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Sterile Injectable Contract Manufacturing market. Additionally, the growing consumer demand present avenues for market expansion.
The global Sterile Injectable Contract Manufacturing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Sterile Injectable Contract Manufacturing market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Sterile Injectable Contract Manufacturing market.
Market Overview: The report provides a comprehensive overview of the Sterile Injectable Contract Manufacturing market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Small Molecule, Large Molecule), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Sterile Injectable Contract Manufacturing market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Sterile Injectable Contract Manufacturing market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Sterile Injectable Contract Manufacturing market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Sterile Injectable Contract Manufacturing market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Sterile Injectable Contract Manufacturing market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Sterile Injectable Contract Manufacturing market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Sterile Injectable Contract Manufacturing, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Sterile Injectable Contract Manufacturing market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Sterile Injectable Contract Manufacturing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Small Molecule
Large Molecule
Market segment by Application
Hospital
Research Laboratory
Others
Global Sterile Injectable Contract Manufacturing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Baxter
Boehringer Ingelheim
Catalent
Grifols S.A.
Vetter Pharma
Recipharm AB
Aenova Group
Fresenius Kabi
Unither Pharmaceuticals
Next Pharma Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sterile Injectable Contract Manufacturing, market overview.
Chapter 2: Global Sterile Injectable Contract Manufacturing market size in revenue.
Chapter 3: Detailed analysis of Sterile Injectable Contract Manufacturing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sterile Injectable Contract Manufacturing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Sterile Injectable Contract Manufacturing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sterile Injectable Contract Manufacturing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sterile Injectable Contract Manufacturing Overall Market Size
2.1 Global Sterile Injectable Contract Manufacturing Market Size: 2022 VS 2029
2.2 Global Sterile Injectable Contract Manufacturing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sterile Injectable Contract Manufacturing Players in Global Market
3.2 Top Global Sterile Injectable Contract Manufacturing Companies Ranked by Revenue
3.3 Global Sterile Injectable Contract Manufacturing Revenue by Companies
3.4 Top 3 and Top 5 Sterile Injectable Contract Manufacturing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Sterile Injectable Contract Manufacturing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sterile Injectable Contract Manufacturing Players in Global Market
3.6.1 List of Global Tier 1 Sterile Injectable Contract Manufacturing Companies
3.6.2 List of Global Tier 2 and Tier 3 Sterile Injectable Contract Manufacturing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Sterile Injectable Contract Manufacturing Market Size Markets, 2022 & 2029
4.1.2 Small Molecule
4.1.3 Large Molecule
4.2 By Type – Global Sterile Injectable Contract Manufacturing Revenue & Forecasts
4.2.1 By Type – Global Sterile Injectable Contract Manufacturing Revenue, 2018-2023
4.2.2 By Type – Global Sterile Injectable Contract Manufacturing Revenue, 2024-2029
4.2.3 By Type – Global Sterile Injectable Contract Manufacturing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Sterile Injectable Contract Manufacturing Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Research Laboratory
5.1.4 Others
5.2 By Application – Global Sterile Injectable Contract Manufacturing Revenue & Forecasts
5.2.1 By Application – Global Sterile Injectable Contract Manufacturing Revenue, 2018-2023
5.2.2 By Application – Global Sterile Injectable Contract Manufacturing Revenue, 2024-2029
5.2.3 By Application – Global Sterile Injectable Contract Manufacturing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Sterile Injectable Contract Manufacturing Market Size, 2022 & 2029
6.2 By Region – Global Sterile Injectable Contract Manufacturing Revenue & Forecasts
6.2.1 By Region – Global Sterile Injectable Contract Manufacturing Revenue, 2018-2023
6.2.2 By Region – Global Sterile Injectable Contract Manufacturing Revenue, 2024-2029
6.2.3 By Region – Global Sterile Injectable Contract Manufacturing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Sterile Injectable Contract Manufacturing Revenue, 2018-2029
6.3.2 US Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.3.3 Canada Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.3.4 Mexico Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Sterile Injectable Contract Manufacturing Revenue, 2018-2029
6.4.2 Germany Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.4.3 France Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.4.4 U.K. Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.4.5 Italy Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.4.6 Russia Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.4.7 Nordic Countries Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.4.8 Benelux Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Sterile Injectable Contract Manufacturing Revenue, 2018-2029
6.5.2 China Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.5.3 Japan Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.5.4 South Korea Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.5.5 Southeast Asia Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.5.6 India Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Sterile Injectable Contract Manufacturing Revenue, 2018-2029
6.6.2 Brazil Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.6.3 Argentina Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Sterile Injectable Contract Manufacturing Revenue, 2018-2029
6.7.2 Turkey Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.7.3 Israel Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.7.4 Saudi Arabia Sterile Injectable Contract Manufacturing Market Size, 2018-2029
6.7.5 UAE Sterile Injectable Contract Manufacturing Market Size, 2018-2029
7 Sterile Injectable Contract Manufacturing Companies Profiles
7.1 Baxter
7.1.1 Baxter Company Summary
7.1.2 Baxter Business Overview
7.1.3 Baxter Sterile Injectable Contract Manufacturing Major Product Offerings
7.1.4 Baxter Sterile Injectable Contract Manufacturing Revenue in Global Market (2018-2023)
7.1.5 Baxter Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Sterile Injectable Contract Manufacturing Major Product Offerings
7.2.4 Boehringer Ingelheim Sterile Injectable Contract Manufacturing Revenue in Global Market (2018-2023)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 Catalent
7.3.1 Catalent Company Summary
7.3.2 Catalent Business Overview
7.3.3 Catalent Sterile Injectable Contract Manufacturing Major Product Offerings
7.3.4 Catalent Sterile Injectable Contract Manufacturing Revenue in Global Market (2018-2023)
7.3.5 Catalent Key News & Latest Developments
7.4 Grifols S.A.
7.4.1 Grifols S.A. Company Summary
7.4.2 Grifols S.A. Business Overview
7.4.3 Grifols S.A. Sterile Injectable Contract Manufacturing Major Product Offerings
7.4.4 Grifols S.A. Sterile Injectable Contract Manufacturing Revenue in Global Market (2018-2023)
7.4.5 Grifols S.A. Key News & Latest Developments
7.5 Vetter Pharma
7.5.1 Vetter Pharma Company Summary
7.5.2 Vetter Pharma Business Overview
7.5.3 Vetter Pharma Sterile Injectable Contract Manufacturing Major Product Offerings
7.5.4 Vetter Pharma Sterile Injectable Contract Manufacturing Revenue in Global Market (2018-2023)
7.5.5 Vetter Pharma Key News & Latest Developments
7.6 Recipharm AB
7.6.1 Recipharm AB Company Summary
7.6.2 Recipharm AB Business Overview
7.6.3 Recipharm AB Sterile Injectable Contract Manufacturing Major Product Offerings
7.6.4 Recipharm AB Sterile Injectable Contract Manufacturing Revenue in Global Market (2018-2023)
7.6.5 Recipharm AB Key News & Latest Developments
7.7 Aenova Group
7.7.1 Aenova Group Company Summary
7.7.2 Aenova Group Business Overview
7.7.3 Aenova Group Sterile Injectable Contract Manufacturing Major Product Offerings
7.7.4 Aenova Group Sterile Injectable Contract Manufacturing Revenue in Global Market (2018-2023)
7.7.5 Aenova Group Key News & Latest Developments
7.8 Fresenius Kabi
7.8.1 Fresenius Kabi Company Summary
7.8.2 Fresenius Kabi Business Overview
7.8.3 Fresenius Kabi Sterile Injectable Contract Manufacturing Major Product Offerings
7.8.4 Fresenius Kabi Sterile Injectable Contract Manufacturing Revenue in Global Market (2018-2023)
7.8.5 Fresenius Kabi Key News & Latest Developments
7.9 Unither Pharmaceuticals
7.9.1 Unither Pharmaceuticals Company Summary
7.9.2 Unither Pharmaceuticals Business Overview
7.9.3 Unither Pharmaceuticals Sterile Injectable Contract Manufacturing Major Product Offerings
7.9.4 Unither Pharmaceuticals Sterile Injectable Contract Manufacturing Revenue in Global Market (2018-2023)
7.9.5 Unither Pharmaceuticals Key News & Latest Developments
7.10 Next Pharma Technologies
7.10.1 Next Pharma Technologies Company Summary
7.10.2 Next Pharma Technologies Business Overview
7.10.3 Next Pharma Technologies Sterile Injectable Contract Manufacturing Major Product Offerings
7.10.4 Next Pharma Technologies Sterile Injectable Contract Manufacturing Revenue in Global Market (2018-2023)
7.10.5 Next Pharma Technologies Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
| 【滅菌注射剤受託製造について】 滅菌注射剤受託製造は、製薬業界における重要なプロセスの一部であり、高度な技術と専門知識が求められる分野です。このプロセスは、製薬企業が自社の製品を市場に送り出すために、外部の専門企業に委託して製造を行う形態を指します。以下では、滅菌注射剤受託製造の概念、特徴、種類、用途、関連技術について詳しく述べます。 まず、滅菌注射剤とは、注射によって体内に投与される薬剤であり、その製造過程において微生物や異物を排除するために厳重な滅菌技術が適用されています。このような製剤は、特に感染症の治療やがん治療、ワクチン接種など、多岐にわたる用途で不可欠です。滅菌注射剤の製造は、品質管理、規制遵守、安全性確保などが非常に重要です。 滅菌注射剤受託製造の特徴には、以下のような点が挙げられます。まず第一に、クリーンルームや特別に設計された製造環境を必要とする点が挙げられます。これにより、外部からの汚染を防ぎ、高品質な製品を保証します。また、受託製造企業は、GMP（適正製造基準）に従った生産プロセスを確立しており、徹底した品質管理が行われます。さらに、製薬企業は、自社での製造設備や人材の確保にかかるコストを節約することができ、より効率的に市場のニーズに応えることが可能となります。 滅菌注射剤受託製造の種類には、様々な製剤形式があります。例えば、アンプルやバイアル、プリフィルドシリンジなどが一般的です。また、製剤の形態には、液体製剤、懸濁液製剤、粉末製剤などがあり、それぞれ異なる製造プロセスや設備が必要です。なお、これらの製剤の特徴に応じて、異なる滅菌方法や充填技術が用いられます。 用途に関しては、滅菌注射剤は、多くの医療分野で使用されており、特にがん治療や感染症治療、疼痛管理、ワクチン開発に関連するものが多いです。そのため、医薬品市場において需要が高まっており、受託製造企業はこの分野での競争力を強化するため、技術革新やサービス向上に努めています。これにより、製薬企業は新薬の迅速な開発・商業化を実現できるだけでなく、患者に対する医療サービスの提供も向上させることができます。 関連技術には、滅菌プロセス、充填・封止技術、包装技術、品質管理システムなどが含まれます。滅菌プロセスとしては、熱滅菌、フィルトレーション、放射線滅菌などがあり、それぞれの製剤に最も適した方法が選択されます。充填・封止技術は、製剤が汚染されるリスクを最小限に抑えるために極めて重要であり、特に無菌分野での技術革新が進められています。包装技術についても、高い保護性能を持つ材料やデザインが求められています。これらの技術はすべて、滅菌注射剤の生産における品質と安全性を確保するために不可欠です。 滅菌注射剤受託製造は、グローバルな製薬業界の中でますます重要な役割を果たしています。製薬企業は、コスト削減や迅速な製品供給を求める中で、外部の専門企業との提携を強化しています。また、受託製造企業は、技術の進化や市場の変化に対応するため、柔軟な製造能力や品質保証プロセスの整備が求められています。このような環境下で、両者の協力はますます重要になるでしょう。 最後に、滅菌注射剤受託製造は、医療と製薬の架け橋として、患者に対して安心・安全な医薬品を供給する役割を担っています。医療技術の進化や新薬の開発加速を背景に、受託製造市場は今後も拡大していくことが予想されます。この分野の技術革新やビジネスモデルの進化に注目が集まり、将来的にはより効率的で高品質な製品の提供が期待されています。 |
